Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Cobamamide-containing composition

A technology of adenosylcobalamin and composition, which is applied in the field of adenosylcobalamin-containing compositions, can solve the problems of insignificant treatment effect of megaloblastic anemia, and achieve the effect of treating megaloblastic anemia

Inactive Publication Date: 2018-06-22
GUANGDONG YIMING PHARMA
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Especially for megaloblastic anemia, malnutrition anemia, anemia during pregnancy and other anemia, it has a strong therapeutic effect, but the therapeutic effect in the treatment of megaloblastic anemia caused by folic acid deficiency is not obvious
[0004] Given that adenosylcobalamin is not effective in the treatment of megaloblastic anemia due to folic acid deficiency

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0011] In order to make the technical means, creative features, goals and effects achieved by the present invention easy to understand, the present invention will be further described below in conjunction with specific embodiments.

[0012] The invention provides a technical solution: a composition containing adenosylcobalamin, which is composed of the following raw materials in parts by weight: 3-9 parts by weight of adenosylcobalamin and 1-2 parts by weight of folic acid.

[0013] As an embodiment of the present invention: it consists of the following raw materials in parts by weight: 5 parts by weight of adenosylcobalamin, and 1 part by weight of folic acid.

[0014] As an embodiment of the present invention: mainly used for megaloblastic anemia, malnutrition anemia, anemia during pregnancy, also for neurological diseases such as multiple neuritis, radiculitis, trigeminal neuralgia, sciatica, nerve Paralysis, nutritional neuropathy, radiation and drug-induced leukopenia, an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a cobamamide-containing composition. The composition is prepared from the following raw materials in part by weight: 3-9 parts of cobamamide and 1-2 part of folic acid. Comparedwith the prior art, the cobamamide-containing composition has the advantage that the medicine composition is prepared by mixing the cobamamide and the folic acid in weight ratio of 3:1 by combining the advantage of the cobamamide, and the megaloblastic anemia caused by the lack of the folic acid can be treated besides the effect of maintaining the original effect of the cobamamide.

Description

technical field [0001] The invention relates to a composition containing adenosylcobalamin, which belongs to the technical field of pharmaceutical preparations. Background technique [0002] Adenosylcobalamin, chemical name: 5,6-dimethylbenzimidazolyl-5'-deoxyadenosylcobalamin; English name: Cobamamide. Adenosylcobalamin is mainly used for megaloblastic anemia, malnutrition anemia, anemia during pregnancy, and also for neurological diseases such as multiple neuritis, radiculitis, trigeminal neuralgia, sciatica, nerve paralysis, nutritional Neurological disorders and leukopenia induced by radiation and drugs. [0003] Adenosylcobalamin has the characteristics of wide application range, safety and effectiveness. Especially for megaloblastic anemia, malnutrition anemia, anemia during pregnancy and other anemia, it has a strong therapeutic effect, but the therapeutic effect in the treatment of megaloblastic anemia caused by folic acid deficiency is not obvious. [0004] In vi...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/714A61K31/519A61P7/06A61P7/00A61P25/00A61P25/02A61P17/00A61P27/02
CPCA61K31/714A61K31/519A61K2300/00
Inventor 李易春洪卓旋郑映君
Owner GUANGDONG YIMING PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com